TTD | Drug: D0W0QF

Drug General Information
Drug ID	D0W0QF
Former ID	DNC012407
Drug Name	4-Methyl-N-(4-phenyl-thiazol-2-yl)-benzamide
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[526099]
Structure		Download 2D MOL 3D MOL
Formula	C17H14N2OS
Canonical SMILES	CC1=CC=C(C=C1)C(=O)NC2=NC(=CS2)C3=CC=CC=C3
InChI	1S/C17H14N2OS/c1-12-7-9-14(10-8-12)16(20)19-17-18-15(11-21-17)13-5-3-2-4-6-13/h2-11H,1H3,(H,18,19,20)
InChIKey	NERONVMZIDSIRT-UHFFFAOYSA-N
PubChem Compound ID	577347
Target and Pathway
Target(s)	Adenosine A1 receptor	Target Info	Inhibitor	[526099]
KEGG Pathway	cGMP-PKG signaling pathway
	cAMP signaling pathway
	Sphingolipid signaling pathway
	Neuroactive ligand-receptor interaction
	Morphine addiction
NetPath Pathway	TCR Signaling Pathway
NetPath Pathway	RANKL Signaling Pathway
PANTHER Pathway	Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
PANTHER Pathway	Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Reactome	Adenosine P1 receptors
Reactome	G alpha (i) signalling events
WikiPathways	Nucleotide GPCRs
	GPCRs, Class A Rhodopsin-like
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 526099	Bioorg Med Chem Lett. 2001 Aug 6;11(15):2017-9.Substituted 4-phenyl-2-(phenylcarboxamido)-1,3-thiazole derivatives as antagonists for the adenosine A(1) receptor.
Ref 526099	Bioorg Med Chem Lett. 2001 Aug 6;11(15):2017-9.Substituted 4-phenyl-2-(phenylcarboxamido)-1,3-thiazole derivatives as antagonists for the adenosine A(1) receptor.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information